Cardiovascular and Oncological Outcomes in Immune Checkpoint Inhibitor-Induced Myocarditis: Balancing Perspectives

JACC CardioOncol. 2023 Dec 19;5(6):745-746. doi: 10.1016/j.jaccao.2023.10.005. eCollection 2023 Dec.

Authors

Leilei Cheng¹, Yuchen Xu², Shilong Zhang³

Affiliations

¹ Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai Institute of Medical Imaging, Shanghai, China.
² Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
³ Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

No abstract available

Keywords: cardio-oncology; immune checkpoint inhibitors; myocarditis; overall survival; rechallenge.

Publication types

Editorial